Literature DB >> 7432882

Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection.

C B Wilson, J S Remington, S Stagno, D W Reynolds.   

Abstract

Most infants born with congenital Toxoplasma infection are asymptomatic in the newborn period, and therefore their infection is not recognized. We performed follow-up evaluations on 24 such children. The mean age of these children at least examination was 8.5 years. In group I (13 children), the diagnosis was made prospectively. In group II (11 children), no symptoms or signs were noted in the newborn period and the diagnosis was made only after the first sign developed. Eighty-five percent of the children in group I and all of the children in group II have developed chorioretinitis. In group I, three children (23%) have unilateral blindness; in group II, three children (27%) and five children (45%) have unilateral and bilateral blindness, respectively. One child (8%) in group I and two children (18%) in group II developed severe, permanent neurologic sequelae after they initially presented with eye disease. Two of the children in each group are now retarded (IQ score range, 36 to 62). Six of the children in group I who were tested sequentially have had lower IQ scores (mean change from 97 to 74) on repeat tests performed an average of 5.5 years later. Less severe neurologic, intellectual, and audiologic deficits were observed in other children in each group. Treatment of some children may have had a beneficial effect on their outcome.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7432882

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  82 in total

Review 1.  Congenital toxoplasmosis.

Authors:  S M Hall
Journal:  BMJ       Date:  1992-08-01

2.  Onset of ocular complications in congenital toxoplasmosis associated with immunoglobulin M antibodies to Toxoplasma gondii.

Authors:  D Sibalić; O Djurković-Djaković; B Bobić
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-09       Impact factor: 3.267

3.  Cell surface heparan sulfate promotes replication of Toxoplasma gondii.

Authors:  Joseph R Bishop; Brett E Crawford; Jeffrey D Esko
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  Possible reasons for failure of conventional tests for diagnosis of fatal congenital toxoplasmosis: report of a case diagnosed by PCR and immunoblot.

Authors:  U Gross; J Müller; T Roos; L Schrod; J Heesemann
Journal:  Infection       Date:  1992 May-Jun       Impact factor: 3.553

5.  Prevalence of congenital Toxoplasma gondii infection among newborns from the Poznań region of Poland: validation of a new combined enzyme immunoassay for Toxoplasma gondii-specific immunoglobulin A and immunoglobulin M antibodies.

Authors:  M Paul; E Petersen; J Szczapa
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

Review 6.  Toxoplasmosis: A history of clinical observations.

Authors:  Louis M Weiss; Jitender P Dubey
Journal:  Int J Parasitol       Date:  2009-02-13       Impact factor: 3.981

7.  Evaluation of a commercial IgG/IgM Western blot assay for early postnatal diagnosis of congenital toxoplasmosis.

Authors:  V Rilling; K Dietz; D Krczal; F Knotek; G Enders
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-05       Impact factor: 3.267

8.  A novel dense granule protein, GRA41, regulates timing of egress and calcium sensitivity in Toxoplasma gondii.

Authors:  Kaice A LaFavers; Karla M Márquez-Nogueras; Isabelle Coppens; Silvia N J Moreno; Gustavo Arrizabalaga
Journal:  Cell Microbiol       Date:  2017-05-17       Impact factor: 3.715

9.  Risk factors for Toxoplasma infection in a reproductive age female population in the area of Belgrade, Yugoslavia.

Authors:  B Bobić; I Jevremović; J Marinković; D Sibalić; O Djurković-Djaković
Journal:  Eur J Epidemiol       Date:  1998-09       Impact factor: 8.082

10.  Evaluation of the Vitros ECiQ immunodiagnostic system for detection of anti-Toxoplasma immunoglobulin G and immunoglobulin M antibodies for confirmatory testing for acute Toxoplasma gondii infection in pregnant women.

Authors:  David C Kasper; Andrea R Prusa; Michael Hayde; Nicole Gerstl; Arnold Pollak; Kurt R Herkner; Rosmarie Reiter-Reisacher
Journal:  J Clin Microbiol       Date:  2008-11-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.